title: Measurement of cdk4 kinase activity using an affinity peptide-tagging technology.
abstract: Cyclin-dependent kinases such as Cdk4 are involved in the control of cell cycle progression, and misregulation of Cdk4 has been implicated in many types of cancers. In the present study, we report the development of a novel homogeneous assay using an affinity peptide-tagging technology for rapidly discovering Cdk4 inhibitors. The DNA sequence encoding a streptavidin recognition motif, or StrepTag (AWRHPQFGG), was cloned and expressed at the C-terminus of a fusion protein of a 152-amino acid hyperphosphorylation domain (Rb152) of the retinoblastoma protein (Rb) linked to GST at the N-terminus. This affinity peptide-tagged protein (GST-Rb152-StrepTag), which contains the two known phosphorylation sites of Rb, specifically phosphorylated by Cdk4 in vivo, was used as a substrate in the current in vitro kinase assay. After phosphorylation, scintillation proximity assay (SPA) scintillant beads coated with streptavidin were added. Radiolabeled GST-Rb152-StrepTag was brought in close proximity to the SPA scintillant beads through the interaction between StrepTag and streptavidin, resulting in the emission of light from beads. By applying the affinity peptide-tagging technology, we have eliminated the separation and wash steps which are normally required in a radioactive filtration assay. Therefore, this homogeneous method is simple, robust, and highly amenable to high-throughput screening of Cdk4-specific inhibitors. Furthermore, the affinity peptide tagging technique reported here is a simple, generic method that can be applied to many recombinant proteins for the development of kinase and protein-protein interaction assays.
authors.affiliation: Novartis Institute for Biomedical Research, Novartis Pharmaceuticals Corporation, Summit, NJ 07901, USA. jinzi.wu@phrma.novartis.com
authors.forename: J J
authors.initials: JJ
authors.lastname: Wu
authors.forename: D R
authors.initials: DR
authors.lastname: Yarwood
authors.forename: M A
authors.initials: MA
authors.lastname: Sills
authors.forename: B
authors.initials: B
authors.lastname: Chaudhuri
authors.forename: L
authors.initials: L
authors.lastname: Muller
authors.forename: M
authors.initials: M
authors.lastname: Zurini
authors.forename: M A
authors.initials: MA
authors.lastname: Sills
mesh_terms: D000345:Affinity Labels; D000595:Amino Acid Sequence; D019938:Cyclin D1 / Q000378:metabolism; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases / Q000378:metabolism*; D005982:Glutathione Transferase / Q000378:metabolism; D010455:Peptides / Q000737:chemistry*; D010766:Phosphorylation; D011518:Proto-Oncogene Proteins; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D019809:Streptavidin / Q000737:chemistry
chemical_list: D000345:Affinity Labels; D010455:Peptides; D011518:Proto-Oncogene Proteins; D011993:Recombinant Fusion Proteins; D019938:Cyclin D1; D019809:Streptavidin; D005982:Glutathione Transferase; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases